Publicació
Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells.
Veure totes les publicacions
Noncyclam tetraamines inhibit CXC chemokine receptor type 4 and target glioma-initiating cells.